ElectroCore is a commercial stage medical device company with a non-invasive vagus nerve stimulation (nVNS) therapy, called gammaCore. nVNS is a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. Co.'s gammaCore therapy is prescription-only, with patients self-administering discrete doses using a handheld unit. Co.'s primary model, gammaCore Sapphire is a portable, reusable, rechargeable and reloadable option for patients, with the prescription being written by a health care provider and dispensed from a specialty pharmacy or fulfilled from its facility in Rockaway, NJ. We show 26 historical shares outstanding datapoints in our coverage of ECOR's shares outstanding history.
Understanding the changing numbers of ECOR shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ECOR versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ECOR by allowing them to research ECOR shares outstanding history
as well as any other stock in our coverage universe. |
Free ECOR Email Alerts:
Video: Shares Outstanding Importance
